Lupin rose 0.92% to Rs 842.90 after the company announced the successful close out of the inspection carried out by the regulatory agency of UK at its three manufacturing units in Pithampur.
Shares of the pharmaceutical company have added 3.64% in two sessions from its recent closing low of Rs 813.30 recorded on 7 May 2020.
Lupin on 8 May 2020 announced the successful close out of the inspection carried out by the Medicines and Healthcare products Regulatory Agency (MHRA), the regulatory agency of the United Kingdom (UK), at its three manufacturing units in Pithampur. The inspection for the three units at Pithampur (Unit I, Unit II and Unit III) was conducted in January 2020. The announcement was made after market hours on Friday (8 May 2020).
Lupin is an innovation-led transnational pharmaceutical company. The company develops and commercializes a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) in over 100 markets across the world.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
